Articles about Life Sciences – Page 4 of 4

Innovative Pulmonary changes name, raises $10M and moves to Minnesota

Innovative Pulmonary Solutions has a new name, a new round of cash and a new headquarters. The medical device company… Read More

OncoGenex finance chief resigns after ‘personal relationship’ develops with CEO

Michelle Burris, the chief financial officer at Bothell biotechnology company OncoGenex Pharmaceuticals, has resigned from her post after disclosing a “developing… Read More

NanoString lands $15.3M for genetic analysis system

NanoString Technologies continues to rake in new capital, announcing today that it has raised $15.3 million from Morgan Stanley Expansion Capital… Read More

Resolve Therapeutics lands $5.8M to crack the code on Lupus

Resolve Therapeutics, a 2-year-old Seattle biotechnology spin off from the University of Washington, has raised $5.8 million in new financing… Read More

Cardiac Dimensions raises $5.8M, sets sights on Europe

Kirkland-based Cardiac Dimensions recently raised $5.8 million in equity, debt and warrants, in order to buy shares from a group… Read More

Dendreon shares sink after plant closure, restructuring

Dendreon, the once-promising Seattle biotechnology company, is taking it on the chin today after announcing a restructuring that will cost… Read More

Nutritional products firm opens new Seattle headquarters

Econet, a South Korean investment holding company, has moved two of its nutritional products companies into a new 70,000 square-foot… Read More

Startup Spotlight: Spiral Genetics offers software to help scientists analyze DNA

DNA analysis allows scientists to dig deep into one’s genetic makeup, discovering if an individual is predisposed to a certain… Read More

Biotech startup VLST raises $5M

VLST Corp., a Seattle biotech developing therapeutics for the treatment of autoimmune and inflammatory diseases, has raised an additional $5… Read More

Can ultrasound reduce blood pressure? Kona Medical lands $30M to find out

The Seattle area continues to be a hotbed of innovation in the field of ultrasound technology, with news today that… Read More

Microsoft co-founder Paul Allen donates $300M to help solve the mysteries of the human brain

Microsoft co-founder Paul Allen is doubling down on his efforts to better understand the human brain, announcing plans today to… Read More

Tech Moves: RealNetworks VP joins Amazon’s Kindle team; etc.

Another day, another executive departure from RealNetworks. Yesterday, we reported that chief financial officer Michael Eggers — a 14-year veteran… Read More

Looking to wipe out wrinkles, JeNu Biosciences lands cash for new skin care device

One of the biggest success stories of 2011 was the sale of David Giuliani’s Pacific Bioscience Laboratories — the maker… Read More

Uptake Medical raises cash for novel emphysema treatment

Uptake Medical, which is developing new medical device technologies to treat emphysema, has raised $35 million of a $41 million venture… Read More

Amazon founder and brainiac Jeff Bezos donates $15 million to Princeton Neuroscience Institute

Microsoft co-founder Paul Allen isn’t the only Seattle billionaire interested in the study of the brain. Amazon.com founder Jeff Bezos… Read More

Startup Spotlight: Vizua looks to bring medical image viewing into the future

Started by former Microsoft employees and a French scientist, Vizua is looking to transform the way radiologists share MRI, CT and… Read More

NanoString lands $20 million

NanoString Technologies, a maker of genomic analysis tools, has raised $20 million in venture capital financing in a deal led… Read More

Biotech veteran Henney inducted into Hall of Fame

Biotech pioneer Christopher Henney has been inducted into the industry’s Hall of Fame, with the announcement made at the annual… Read More

Ultrasound on the go? Smartphone-based imaging system released by Mobisante

Ultrasound systems can be bulky and expensive. But a Redmond company by the name of Mobisante is looking to transform… Read More

Venture capitalist Thong Le tapped as chair of biotech group

Thong Le, the managing director of WRF Capital, has been named chairman of the Washington Biotechnology and Biomedical Association. Le… Read More

Calypso’s GPS system for tumor tracking acquired for $10M

Calypso Medical Technologies, a Seattle company which has developed a system to pinpoint tumors in the body, has been acquired… Read More

RF Surgical raises $12 million to detect lost surgical sponges

RF Surgical Systems has raised $12 million, money that the Bellevue company will use to enhance its RFID technology for… Read More

Theraclone Sciences raises $10M

Theraclone Sciences, a Seattle biotechnology company that’s developing a method to rapidly identify disease-fighting antivbodies, has attracted $10.6 million. Investors… Read More

Cell imaging company Amnis acquired by EMD Millipore

Amnis, a 12-year-old Seattle company which provides high-speed cell imaging instruments, has been sold to EMD Millipore for an undisclosed… Read More

Fred Hutchinson Cancer Research Center wins $8.2M grant to study link between obesity and cancer

The American Cancer Society estimates that about 30 percent of cancer deaths are tied to poor nutrition, lack of exercise… Read More

Atossa raises $6.6M to roll out a ‘Pap test for breast cancer’

Atossa Genetics, which is developing testing technologies to detect the presence of breast cancer, has raised $6.6 million in new… Read More

Stratos Genomics raises $2.2 million for DNA sequencer

Stratos Genomics said today that it has raised an additional $2.1 million from existing shareholders. The money, which follows a… Read More

A Hubble Telescope for the immune system: Seattle’s Adaptive TCR raises $5.8M

Adaptive TCR, a Seattle company that’s attempting to profile and measure the body’s immune system, has raised $5.8 million in… Read More

Accelerator Corp. hatches Oncofactor, a new Seattle cancer research startup

Accelerator Corp. has backed its 12th startup, a cancer research company that’s attempting to disrupt signaling pathways between tumors and the… Read More

HIV drug maker Koronis considers IPO in London

We’ve bemoaned the fact that very few Seattle area companies are considering initial public offerings. But Koronis Pharmaceuticals, a Seattle… Read More